何氏眼科
(301103)
| 流通市值：20.71亿 | | | 总市值：26.91亿 |
| 流通股本：1.22亿 | | | 总股本：1.58亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 585,092,897.33 | 305,184,437.79 | 1,092,618,730.41 | 855,274,926.4 |
| 营业总成本 | 534,045,393.17 | 265,692,066.29 | 1,048,951,940.54 | 786,489,696.96 |
| 其他经营收益 | | | | |
| 营业利润 | 58,799,660.7 | 42,210,252.36 | 58,152,204.65 | 81,683,638.08 |
| 利润总额 | 57,597,874.47 | 41,608,676.47 | 56,034,775.92 | 80,467,052.81 |
| 净利润 | 41,385,282.65 | 32,611,617.14 | 26,404,935.55 | 53,557,958.28 |
| 每股收益 | | | | |
| 其他综合收益 | 10,824.07 | -7,446.42 | 3,785.21 | -12,246.02 |
| 综合收益总额 | 41,396,106.72 | 32,604,170.72 | 26,408,720.76 | 53,545,712.26 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,481,753,597.8 | 1,494,633,116.18 | 1,472,807,168.24 | 1,519,747,430.48 |
| 非流动资产: | | | | |
| 非流动资产合计 | 719,313,251.87 | 737,545,562.48 | 708,973,805.56 | 734,564,421.72 |
| 资产总计 | 2,201,066,849.67 | 2,232,178,678.66 | 2,181,780,973.8 | 2,254,311,852.2 |
| 流动负债: | | | | |
| 流动负债合计 | 158,348,510.35 | 175,353,334.8 | 163,811,498.68 | 195,988,437.16 |
| 非流动负债: | | | | |
| 非流动负债合计 | 132,128,905.65 | 135,821,718.14 | 133,659,454.75 | 148,059,741.7 |
| 负债合计 | 290,477,416 | 311,175,052.94 | 297,470,953.43 | 344,048,178.86 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,910,240,563.11 | 1,920,583,907.54 | 1,883,813,108.81 | 1,909,672,611.98 |
| 股东权益合计 | 1,910,589,433.67 | 1,921,003,625.72 | 1,884,310,020.37 | 1,910,263,673.34 |
| 负债和股东权益合计 | 2,201,066,849.67 | 2,232,178,678.66 | 2,181,780,973.8 | 2,254,311,852.2 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 627,965,910.31 | 326,997,710.97 | 1,180,990,536.69 | 929,150,478.68 |
| 经营活动现金流出小计 | 529,260,051.13 | 250,921,968.19 | 1,024,056,043.01 | 758,650,556.48 |
| 经营活动产生的现金流量净额 | 98,705,859.18 | 76,075,742.78 | 156,934,493.68 | 170,499,922.2 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,460,371,097.7 | 379,347,402.58 | 3,214,305,510.2 | 2,287,819,378.03 |
| 投资活动现金流出小计 | 1,685,230,111 | 618,803,257.98 | 3,524,749,452.93 | 2,805,217,784.41 |
| 投资活动产生的现金流量净额 | -224,859,013.3 | -239,455,855.4 | -310,443,942.73 | -517,398,406.38 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 240,000 | 240,000 |
| 筹资活动现金流出小计 | 45,929,616.27 | 11,005,878.54 | 73,871,352.62 | 57,268,042.11 |
| 筹资活动产生的现金流量净额 | -45,929,616.27 | -11,005,878.54 | -73,631,352.62 | -57,028,042.11 |
| 汇率变动对现金及现金等价物的影响 | 6,474.62 | 9,107.1 | 748.9 | 56,154.3 |
| 现金及现金等价物净增加额 | -172,076,295.77 | -174,376,884.06 | -227,140,052.77 | -403,870,371.99 |
| 期末现金及现金等价物余额 | 366,812,153.21 | 364,511,564.92 | 538,888,448.98 | 362,158,129.76 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -172,076,295.77 | - | -227,140,052.77 | - |